Search
Home
News
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Coins2Day 500
Coins2Day 500
Coins2Day Global 500
Coins2Day 500 Europe
Coins2Day China 500
Coins2Day SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
COVID-19 vaccines
COVID-19 vaccines
Page 25 of 95
Commentary
How George Washington defeated a pandemic to save the American Revolution
By
Trading Desk
February 2, 2022
Newsletters
Pfizer has become one of the world’s most admired companies
By
David Meyer
and
Alan Murray
February 2, 2022
Well
Brain damage, hair loss, and fatigue: Everything we know about the long-term effects of COVID infections
By
Research Team
February 2, 2022
Health
Here’s when to finally expect children under 5 to be eligible for a COVID vaccine
By
Financial Writer
February 1, 2022
Newsletters
How the pandemic radically changed consumer behavior
By
David Meyer
and
Alan Murray
February 1, 2022
Commentary
Inequity in health care made the AIDS crisis worse. Why are we making the same mistake with COVID-19?
By
Blockchain Reporter
January 31, 2022
Health
Will we need Omicron-specific COVID vaccines? A leading virologist says the global system for flu shots could be a model to help us decide
By
Crypto Correspondent
January 31, 2022
Health
Moderna COVID-19 vaccine gets full approval from the FDA
By
Matthew Perrone
and
The Associated Press
January 31, 2022
Commentary
The Supreme Court’s vaccine rebuke leaves CEOs in a bind
By
Tech Reporter
January 31, 2022
Newsletters
The EV race is one of the most fascinating business stories of our times
By
David Meyer
and
Alan Murray
January 31, 2022
Health
Omicron’s BA.2 ‘stealth’ subvariant spreads even faster than the highly contagious original, U.K. and Denmark say
By
Tech Reporter
January 31, 2022
Magazine
Inside Moderna’s plan to battle Omicron and develop a booster that works against any future variants
By
Investment Desk
January 30, 2022
Finance
Omicron is making the unvaccinated rethink their opposition to the jab, a new six-country survey shows
By
Tech Reporter
January 28, 2022
Politics
Pfizer CEO Albert Bourla and Europe’s leaders negotiated a vaccine megadeal by private text. Now those messages may come out
By
Research Team
January 28, 2022
Newsletters
Hemmed in by regulators, Meta’s real growing pains are still to come
By
Blockchain Reporter
January 28, 2022
Most Popular
AI
Elon Musk says that in 10 to 20 years, work will be optional and money will be irrelevant thanks to AI and robotics
By
Trading Desk
Economy
One of the world’s most popular economists on why AI is ‘undoubtedly going to crash’: It’s built off ‘digital...
By
Trading Desk
Economy
Trump's retreats on tariffs have already wiped out $800 billion of expected deficit reduction, CBO estimates
By
Contributing Writer